HSANZ Free Communications 7: Albert Baikie Memorial Medal Session
Tracks
HSANZ
Tuesday, November 7, 2023 |
10:30 AM - 12:00 PM |
Plenary 3 |
Speaker
Dr Briony Shaw
Monash Health
Interventions and therapy at end of life in haematological malignancy: A retrospective cohort study on healthcare utilisation and palliative care use
10:30 AM - 10:45 AMBiography
Dr Briony Shaw is a clinical and laboratory haematologist (Monash Health) and NHMRC-funded PhD candidate (Monash University) focusing on piloting a home blood transfusion program for haematology patients. She has a particular passion for managing elderly patients and improving supportive care in haematological malignancy.
Dr James Kuzich
Haematologist
Peter MacCallum Cancer Centre
Clonal and transcriptional determinants of post-CAR T cell relapse in B-cell acute lymphoblastic leukaemia
10:45 AM - 11:00 AMBiography
Dr Jamie Kuzich is a clinical haematologist at the Peter MacCallum Cancer Centre & Royal Melbourne Hospital, where he works within the CAR-T and lymphoma streams. He is currently completing a PhD investigating CAR T cell resistance mechanisms, supervised by Prof Mark Dawson.
Dr Jad Othman
Haematologist
Royal North Shore Hospital
Molecular MRD assessment is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based non-intensive therapy
11:00 AM - 11:15 AMBiography
Jad Othman is an early career haematologist from Royal North Shore Hospital. He has an interest in AML, molecular genomics and MRD. He has recently completed a fellowship with the UK NCRI MRD group at Guy's Hospital and Kings College London, which was generously supported by HSANZ.
Dr Annie Reale
Adjunct Research Fellow
Monash University
Multiple myeloma-derived circulating extracellular vesicles affect normal human stromal cell behaviour and promote tumor progression: a multi-omic approach
11:15 AM - 11:30 AMBiography
Antonia Reale, a post-doc at the Myeloma Research Group, Monash University in Melbourne, completed her MD in 2010 and specialized in Medical Oncology in Bari-IT. Her research focuses on understanding the role of EVs in MM. Dr Reale has numerous peer-reviewed publications and has presented at national and international conferences.
Dr Trung Ngo
Haematology Registrar
Monash Health
Next generation sequencing RNA Fusion Panel for the diagnosis of haematological malignancies – an Australian first.
11:30 AM - 11:45 AMBiography
Dr Trung Ngo is a joint haematology trainee at Monash Health. He has interests in malignant haematology and its intersect with the rapidly expanding field of molecular pathology. His research is based at Monash's Genetics and Molecular Pathology (GMP) laboratory.
Dr Rebecca Wayte
BMT/Cellular Therapy Fellow
Royal Prince Alfred Hospital
Tisagenlecleucel for relapsed/refractory high grade B cell lymphoma: a single centre Australian experience
11:45 AM - 12:00 PMBiography
Dr Rebecca Wayte is the current bone marrow transplantation and cellular therapy fellow at Royal Prince Alfred Hospital in Sydney. She trained at Royal Prince Alfred, Westmead and Concord Hospitals and has a particular interest in transplantation and cellular therapies.
Chairperson
Steven Lane
President, HSANZ
Haematology Society of Australia and New Zealand
Hui-Peng Lee
Consultant Haematologist
Flinders Medical Centre / HSANZ